152 related articles for article (PubMed ID: 34097324)
21. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.
Peng Q; Yang S; Lao X; Tang W; Chen Z; Lai H; Wang J; Sui J; Qin X; Li S
PLoS One; 2014; 9(4):e94790. PubMed ID: 24733273
[TBL] [Abstract][Full Text] [Related]
23. CDH1 promoter polymorphism and stomach cancer susceptibility.
Li YL; Tian Z; Zhang JB; Fu BY
Mol Biol Rep; 2012 Feb; 39(2):1283-6. PubMed ID: 21625863
[TBL] [Abstract][Full Text] [Related]
24. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
25. CDH1 rs9929218 variant at 16q22.1 contributes to colorectal cancer susceptibility.
Han P; Liu G; Lu X; Cao M; Yan Y; Zou J; Li X; Wang G
Oncotarget; 2016 Jul; 7(30):47278-47286. PubMed ID: 27259261
[TBL] [Abstract][Full Text] [Related]
26. Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.
Zhao L; Wang YX; Xi M; Liu SL; Zhang P; Luo LL; Liu MZ
Int J Clin Exp Pathol; 2015; 8(5):5753-60. PubMed ID: 26191293
[TBL] [Abstract][Full Text] [Related]
27. E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer.
de Lima JM; de Souza LG; da Silva ID; Forones NM
Int J Biol Markers; 2009; 24(2):99-106. PubMed ID: 19634113
[TBL] [Abstract][Full Text] [Related]
28. Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women.
Rahman MA; Hasan MM; Hossain A; Alam KM; Sultana R; Mazid MA; Rahman MM
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2361-2368. PubMed ID: 37505767
[TBL] [Abstract][Full Text] [Related]
29. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
30. rs719725 Polymorphism and Colorectal Cancer Susceptibility: A Meta-analysis.
Zhou X; Chen A; Zhang T
J Coll Physicians Surg Pak; 2023 May; 33(5):566-571. PubMed ID: 37190694
[TBL] [Abstract][Full Text] [Related]
31. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
[TBL] [Abstract][Full Text] [Related]
32. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
[TBL] [Abstract][Full Text] [Related]
33. TNF-α-308G/A polymorphism and the risk of colorectal cancer: A systematic review and an updated meta-analysis.
Miao Z; Wang K; Wang X; Zhang C; Xu Y
J BUON; 2018; 23(6):1616-1624. PubMed ID: 30610785
[TBL] [Abstract][Full Text] [Related]
34. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism.
Cavalcante RB; Nonaka CF; Rabenhorst SH; da Costa Miguel MC; Pinto LP; de Souza LB
Arch Oral Biol; 2017 Jan; 73():48-54. PubMed ID: 27665273
[TBL] [Abstract][Full Text] [Related]
36. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
[TBL] [Abstract][Full Text] [Related]
37. Association between the epithelial cadherin -160C/A gene polymorphism and diffuse gastric cancer risk: a meta-analysis.
Chen XW; Sun JX; Wang ZN; Gao P; Song YX; Cao JF; Liu B; Xu HM
Genet Mol Res; 2014 Feb; 13(1):850-9. PubMed ID: 24615049
[TBL] [Abstract][Full Text] [Related]
38. The -160C>a polymorphism in E-cadherin is associated with the risk of nephrolithiasis.
Tan M; Xia S; Zhang Q; Zhu J; Bao E
PLoS One; 2013; 8(9):e73109. PubMed ID: 24023817
[TBL] [Abstract][Full Text] [Related]
39. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
